MK-5684

MK-5684 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK-5684, covering 2024-10-15 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) [Phase 2]